From: Burden of illness of trigeminal neuralgia among patients managed in a specialist center in England
Pain | Medication | Surgery | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Total Sample | Any attacks in past 4 weeks | No attacks in past 4 weeks | Current monotherapy | Current poly therapy | No current therapy | No surgery | MVD only | Ablative surgery | MVD + ablative surgery | |
Total N | 129 | 59 | 69 | 49 | 35 | 45 | 77 | 30 | 13 | 8 |
Age, Continuous (years,%) | ||||||||||
Mean (SD) | 65.7 (12) | 66.2 (11) | 65.1 (12) | 69.3 (11) | 64.8 (11) | 62.6 (11) | 67.4 (11) | 61.5 (11) | 69.1 (13) | 60.9 (8) |
Median (IQR) | 67.0 (59, 73) | 68.0 (58, 74) | 67.0 (60, 72) | 71.0 (62, 79) | 66.0 (55, 74) | 64.0 (57, 71) | 69.0 (61, 74) | 63.0 (51, 71) | 71.0 (65, 82) | 63.5 (53.5, 67) |
Min/Max | 39/85 | 39/85 | 41/85 | 39/85 | 47/85 | 41/79 | 39/85 | 42/79 | 44/84 | 49/70 |
Age, Categories (n, %) | ||||||||||
35–44 | 6 (5) | 2 (3) | 4 (6) | 2 (4) | 0 | 4 (8.9) | 4 (5.2) | 1 (3) | 1 (8) | 0 |
45–54 | 17 (13) | 7 (12) | 10 (15) | 2 (4) | 8 (23) | 7 (16) | 5 (7) | 9 (30) | 1 (8) | 2 (25) |
55–64 | 29 (23) | 15 (25) | 14 (20) | 11 (22) | 6 (17) | 12 (27) | 18 (23) | 7 (23) | 1 (8) | 2 (25) |
65+ | 77 (60) | 35 (59) | 41 (59) | 34 (69) | 21 (60) | 22 (49) | 50 (65) | 13 (43) | 10 (77) | 4 (50) |
Gender, n (%) | ||||||||||
Female | 84 (65) | 37 (63) | 46 (67) | 32 (65) | 20 (57) | 32 (71) | 54 (70) | 19 (63) | 7 (54) | 4 (50) |
Male | 45 (35) | 22 (37) | 23 (33) | 17 (35) | 15 (43) | 13 (29) | 23 (30) | 11 (37) | 6 (46) | 4 (50) |
Race, n (%) | ||||||||||
White | 113 (88) | 51 (86) | 61 (88) | 42 (86) | 30 (86) | 41 (91) | 66 (86) | 27 (90) | 12 (92) | 7 (88) |
Asian/Asian British | 8 (6) | 3 (5) | 5 (7) | 5 (10) | 1 (3) | 2 (4) | 7 (9) | 1 (3) | 0 | 0 |
Black/African/Caribbean/Black British | 7 (5) | 5 (9) | 2 (3) | 1 (2) | 4 (11) | 2 (4) | 4 (5) | 2 (7) | 0 | 1 (13) |
Other | 1 (1) | 0 | 1 (1) | 1 (2) | 0 | 0 | 0 | 0 | 1 (8) | 0 |